Benjamin Lin

Benjamin Lin is currently the Biologics Global Analytical Validation Modernization Lead at AstraZeneca, where they leverage their analytical skills in the field of cell therapy. Previously, they served as a Cell Therapy Project Coordinator and Procurement Specialist at the same company. In 2021, Benjamin contributed as an Associate Engineer in R&D at Patek Pneumatics, where they developed their engineering expertise through diverse challenges. They hold an MBA from the Simon Business School at the University of Rochester, further enhancing their knowledge in operations and strategy. Benjamin is recognized for their strong leadership, teamwork, and problem-solving abilities throughout their academic and professional journey.